Summary
Heart transplantation (Tx) started in Europe in March 1968 in our group in La Pitié, which performed the seventh cardiac Tx in the world. So far, more than 3000 such operations have been performed in Europe by more than 120 centers. The main problem remains the shortage of donors, which cannot match the needs, and which necessitates a careful selection of the recipients, avoiding patients with infection, too high pulmonary hypertension, or an age of over 60 years. Orthotopic Tx is the most frequent technique used, and the main postoperative problems are: hemodynamic instability during the first week; rejection, detected by endomyocardial biopsy and now various noninvasive methods; and the side effects of the immunosuppressive drugs (cyclosporine, azathioprine, corticoids, antilymphocyte globulin (ALG), or OKT3 monoclonal antibody). The overall survival rate at 7 years is 65%, with full rehabilitation of the survivors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jamieson SW, Oyer P; Baldwin J, Billingham M, Stinson E, Shumway N (1984) Heart transplantation for endstage ischemic heart disease: The stanford experience. Heart Trans 3:224–227
Bailey LL, Concepcion W, Shattuck H, Lou Huang (1986) Method of heart transplantation for treatment of hypoplastic left syndrome. J Thorac Cardiovasc Surg 92:1–5
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Tokyo
About this paper
Cite this paper
Cabrol, C. et al. (1991). Heart transplantation — Status in Europe. In: Akutsu, T., et al. Artificial Heart 3. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68126-7_31
Download citation
DOI: https://doi.org/10.1007/978-4-431-68126-7_31
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68128-1
Online ISBN: 978-4-431-68126-7
eBook Packages: Springer Book Archive